Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation

SJ Singh, MM Baldwin, E Daynes, RA Evans… - The Lancet …, 2023 - thelancet.com
Although the exact prevalence of post-COVID-19 condition (also known as long COVID) is
unknown, more than a third of patients with COVID-19 develop symptoms that persist for …

[HTML][HTML] The impact of SARS-CoV-2 infection in patients with cystic fibrosis undergoing CFTR channel modulators treatment: a literature review

A Vitiello, M Sabbatucci, A Silenzi, A Capuano… - Respiratory …, 2023 - Springer
Several risk factors for Coronavirus-2019 (COVID-19) disease have been highlighted in
clinical evidence. Among the various risk factors are advanced age, metabolic illness such …

Covid-19 in cystic fibrosis patients compared to the general population: Severity and virus-host cell interactions

F Ciciriello, F Panariello, P Medino, A Biffi… - Journal of Cystic …, 2024 - Elsevier
Background People with cystic fibrosis (pwCF) are considered at risk of developing severe
forms of respiratory viral infections. We studied the consequences of COVID-19 and virus …

A year in review (2022): Modulators and COVID19, the story goes on…

S Dillenhoefer, D Grogono, A Morales-Tirado - Journal of Cystic Fibrosis, 2023 - Elsevier
In this review we have aimed to cover some of the highlights of the cystic fibrosis (CF)
literature in 2022, which again has been dominated by the SARS-CoV-2 (COVID-19) …

[PDF][PDF] The impact of SARS-CoV-2 infection in patients with cystic fibrosis undergoing CFTR channel modulators treatment: a literature

A Vitiello, M Sabbatucci, A Silenzi, A Capuano… - 2023 - respiratory-research.biomedcentral …
Several risk factors for Coronavirus-2019 (COVID-19) disease have been highlighted in
clinical evidence. Among the various risk factors are advanced age, metabolic illness such …